Immunic, Inc. (IMUX) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Immunic, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.357 -- 00:00:05.158 Good morning to everybody on the line. I would like to welcome you to Immunix's fourth 00:00:05.158 -- 00:00:10.159 quarter and year-end 2023 earnings call. My name is Jessica Bru, Vice President 00:00:10.159 -- 00:00:12.680 Investor Relations and Communications at Immunix. 00:00:12.680 -- 00:00:16.201 I will also be the moderator today. Speaking on the call are Dr. 00:00:16.201 -- 00:00:20.502 Daniel Fitt, our Chief Executive Officer and President, as well as Glenn Whaley, our 00:00:20.502 -- 00:00:25.326 Chief Financial Officer. Please note that all participants will be in listen-only mode, 00:00:25.326 -- 00:00:30.130 and this event is being recorded. After today's presentation, there will be an opportunity 00:00:30.130 -- 00:00:34.754 to ask questions. If you joined the webcast via the Zoom platform, there are two ways 00:00:34.754 -- 00:00:39.138 to submit questions. You can either submit your questions in writing via the Q&A tool 00:00:39.138 -- 00:00:44.663 of the Zoom portal, or if you would like to speak with us directly, please use the raise 00:00:44.663 -- 00:00:48.465 hand function in the Zoom portal to queue your question. 00:00:48.479 -- 00:00:52.964 Before we begin, I would like to remind you that this presentation may contain forward-looking 00:00:52.964 -- 00:00:58.449 statements. Such statements can be identified by words such as may, will, expect, anticipate, 00:00:58.449 -- 00:01:02.874 estimate, or words with a similar meaning, and such statements involve a number of risks 00:01:02.874 -- 00:01:07.178 and uncertainties that could cause Immunex's actual results to differ materially from 00:01:07.178 -- 00:01:11.762 those discussed here. Please note that these forward-looking statements reflect Immunix's 00:01:11...